MENU
+Compare
CHGCY
Stock ticker: OTC
AS OF
Jun 13 closing price
Price
$25.91
Change
-$0.38 (-1.45%)
Capitalization
49.42B

CHGCY Chugai Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company... Show more

CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CHGCY with price predictions
Jun 13, 2025

CHGCY sees its Stochastic Oscillator recovers from oversold territory

On May 20, 2025, the Stochastic Oscillator for CHGCY moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHGCY advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 194 cases where CHGCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CHGCY as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CHGCY turned negative on June 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

CHGCY moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CHGCY crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHGCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CHGCY broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHGCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.634) is normal, around the industry mean (5.632). P/E Ratio (21.459) is within average values for comparable stocks, (48.974). CHGCY's Projected Growth (PEG Ratio) (15.938) is very high in comparison to the industry average of (3.004). Dividend Yield (0.019) settles around the average of (0.161) among similar stocks. P/S Ratio (5.643) is also within normal values, averaging (3.643).

View a ticker or compare two or three
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

CHGCY paid dividends on April 12, 2024

Chugai Pharmaceutical Co., Ltd. CHGCY Stock Dividends
А dividend of $0.13 per share was paid with a record date of April 12, 2024, and an ex-dividend date of December 28, 2023. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
1-1 Nihonbashi-Muromachi 2-Chome
Phone
+81 332816611
Employees
7432
Web
http://www.chugai-pharm.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NREEX13.99-0.09
-0.64%
Neuberger Berman Real Estate E
NRCFX12.71-0.11
-0.86%
Natixis AEW Global Focused Real Estate C
BWLYX23.37-0.23
-0.97%
American Beacon Man Lg Cp Value Y
NBMBX17.57-0.19
-1.07%
Neuberger Berman Mid Cap Growth Adv
STESX15.27-0.17
-1.10%
Bernstein International Strat Eqs SCB

CHGCY and Stocks

Correlation & Price change

A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
-1.45%
CHGCF - CHGCY
32%
Poorly correlated
-9.06%
OTSKY - CHGCY
30%
Poorly correlated
-1.29%
OPHLY - CHGCY
22%
Poorly correlated
-1.65%
DSNKY - CHGCY
22%
Poorly correlated
-2.36%
RHHBY - CHGCY
20%
Poorly correlated
-1.50%
More